Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic Mastectomy Sharyl J. NassLarissa Nekhlyudov Breast Oncology 05 January 2017 Pages: 611 - 613
Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer? Judy C. BougheyBruce G. HafftyMatthew P. Goetz Breast Oncology 04 January 2017 Pages: 614 - 617
Axillary Ultrasound Before Neoadjuvant Chemotherapy for Breast Cancer: Don’t Discount the Benefits Yet! Theresa L. SchwartzJulie A. Margenthaler Breast Oncology 17 January 2017 Pages: 618 - 620
Extending ACOSOG Z0011 to Encompass Mastectomy: What Happens Without RT? Hiram S. Cody III Breast Oncology 30 September 2016 Pages: 621 - 623
Cancer Research in Low- and Middle-Income Countries: Consortiums, Implementation Science and Healthcare Delivery Benjamin O. Anderson Healthcare Policy and Outcomes 15 November 2016 Pages: 624 - 626
Establishing a Cancer Research Consortium in Low- and Middle-Income Countries: Challenges Faced and Lessons Learned Sara E. FischerOlusegun I. AlatiseT. Peter Kingham Healthcare Policy and Outcomes 14 October 2016 Pages: 627 - 631
Influence of the SSO/ASTRO Margin Reexcision Guidelines on Costs Associated with Breast-Conserving Surgery C. R. BaliskiR. E. Pataky Health Services Research and Global Oncology 23 November 2016 Pages: 632 - 637
Postoperative Complications and Long-Term Survival After Complex Cancer Resection Hari NathanHuiying YinSandra L. Wong Healthcare Policy and Outcomes 12 September 2016 Pages: 638 - 644
Is Routine Axillary Imaging Necessary in Clinically Node-Negative Patients Undergoing Neoadjuvant Chemotherapy? Andrea V. BarrioAnita MamtaniMonica Morrow Breast Oncology 27 January 2017 Pages: 645 - 651
Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy Elizabeth FitzSullivanRoland L. BassettRosa Hwang Breast Oncology 03 October 2016 Pages: 652 - 659
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ Jennifer B. MandersHenry M. KuererStudy investigators and study participants Breast Oncology Open access 04 October 2016 Pages: 660 - 668
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping Pat WhitworthPeter BeitschJennifer Beatty Breast Oncology Open access 21 October 2016 Pages: 669 - 675
Ultrasound-Guided Core-Needle Versus Vacuum-Assisted Breast Biopsy: A Cost Analysis Based on the American Society of Breast Surgeons’ Mastery of Breast Surgery Registry Ian GradyTony VasquezSean Grady Breast Oncology 06 October 2016 Pages: 676 - 682
Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis Heather B. NeumanJessica R. SchumacherCaprice C. Greenberg Breast Oncology 05 October 2016 Pages: 683 - 691
The Impact of Primary Care Providers on Patient Screening Mammography and Initial Presentation in an Underserved Clinical Setting Ajaratu KeshinroIoannis HatzarasKathie-Ann Joseph Breast Oncology 20 October 2016 Pages: 692 - 697
Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age Julia C. RadosaAnne EatonTari A. King Breast Oncology 25 October 2016 Pages: 698 - 704
The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review Kathryn WaiteHaney Youssef Colorectal Cancer 05 January 2017 Pages: 705 - 720
Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer E. B. ThorgersenM. A. GoscinskiK. Flatmark Colorectal Cancer 20 October 2016 Pages: 721 - 728
When and When Not to Perform a Right Colon Resection with Mucinous Appendiceal Neoplasms Paul H. Sugarbaker Colorectal Cancer 21 October 2016 Pages: 729 - 732
Intraoperative Parathyroid Hormone Levels at 5 min Can Identify Multigland Disease Amal AlhefdhiKamal AhmadDavid F. Schneider Endocrine Tumors 14 October 2016 Pages: 733 - 738
Thyroglobulin Measurement in Fine-Needle Aspiration Improves the Diagnosis of Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma Zahraa Al-HilliVeljko StrajinaMelanie L. Richards Endocrine Tumors 13 October 2016 Pages: 739 - 744
Increasing the Number of Examined Lymph Nodes is a Prerequisite for Improvement in the Accurate Evaluation of Overall Survival of Node-Negative Gastric Cancer Patients Jingyu DengHiroharu YamashitaHan Liang Gastrointestinal Oncology 21 October 2016 Pages: 745 - 753
The Preoperative Frailty Versus Inflammation-Based Prognostic Score: Which is Better as an Objective Predictor for Gastric Cancer Patients 80 Years and Older? Jun LuLong-long CaoChang-ming Huang Gastrointestinal Oncology 02 November 2016 Pages: 754 - 762
Esophageal Cancer Surgery for Patients with Concomitant Liver Cirrhosis: A Single-Center Matched-Cohort Study Michele ValmasoniElisa Sefora PierobonStefano Merigliano Gastrointestinal Oncology 04 October 2016 Pages: 763 - 769
Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma In-Ho KimIn Hee LeeJin Hyoung Kang Thoracic Oncology 30 September 2016 Pages: 770 - 777
Comparison of Salvage Total Pharyngolaryngectomy and Cervical Esophagectomy Between Hypopharyngeal Cancer and Cervical Esophageal Cancer Katsushi TakebayashiYasuhiro TsubosaTetsuro Onitsuka Head and Neck Oncology 06 October 2016 Pages: 778 - 784
Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients Chun-Ta LiaoYu-Wen Wenfor the Taiwan Oral Cancer Advisory Group Head and Neck Oncology 28 November 2016 Pages: 785 - 793
Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival Rachel GrossmanNir ShimonyZvi Ram Neuro-Oncology 20 October 2016 Pages: 794 - 800
Long-Term Outcomes of 98 Surgically Resected Metastatic Tumors in the Pancreas Shin-Rong LeeGeorgios GemenetzisMatthew J. Weiss Pancreatic Tumors 21 October 2016 Pages: 801 - 807
Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer Marek SierzegaMarzena LenartJan Kulig Pancreatic Tumors Open access 21 October 2016 Pages: 808 - 815
Prior Radiotherapy Does Not Affect Abdominal Wall Reconstruction Outcomes: Evidence from Propensity Score Analysis Salvatore GiordanoPatrick B. GarveyCharles E. Butler Reconstructive Oncology 30 September 2016 Pages: 816 - 822
Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy Takashi YoshidaHidefumi KinoshitaTadashi Matsuda Urologic Oncology 11 October 2016 Pages: 823 - 831
CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma Masakazu GotoTakahiro YoshidaAkira Tangoku Translational Research and Biomarkers 17 November 2015 Pages: 832 - 840
Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer Yujiro NishizawaNaohiro NishidaHideshi Ishii Translational Research and Biomarkers 29 July 2016 Pages: 841 - 849
Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma Hisateru KomatsuTomohiro IguchiKoshi Mimori Translational Research and Biomarkers 21 October 2016 Pages: 850 - 859
